KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Biolife Solutions (BLFS) Long-Term Debt Issuances (2016 - 2022)

Historic Long-Term Debt Issuances for Biolife Solutions (BLFS) over the last 9 years, with Q3 2022 value amounting to $20.0 million.

  • Biolife Solutions' Long-Term Debt Issuances rose 548659.22% to $20.0 million in Q3 2022 from the same period last year, while for Dec 2023 it was $20.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $20.0 million for FY2022, which is 119032.26% up from last year.
  • As of Q3 2022, Biolife Solutions' Long-Term Debt Issuances stood at $20.0 million, which was up 548659.22% from -$90000.0 recorded in Q4 2021.
  • Over the past 5 years, Biolife Solutions' Long-Term Debt Issuances peaked at $20.0 million during Q3 2022, and registered a low of -$2.2 million during Q4 2020.
  • Its 3-year average for Long-Term Debt Issuances is $3.1 million, with a median of $358000.0 in 2021.
  • In the last 5 years, Biolife Solutions' Long-Term Debt Issuances crashed by 8942.53% in 2021 and then surged by 548659.22% in 2022.
  • Quarter analysis of 3 years shows Biolife Solutions' Long-Term Debt Issuances stood at -$2.2 million in 2020, then skyrocketed by 95.86% to -$90000.0 in 2021, then skyrocketed by 22322.22% to $20.0 million in 2022.
  • Its last three reported values are $20.0 million in Q3 2022, -$90000.0 for Q4 2021, and $358000.0 during Q3 2021.